Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl) pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory diseaseSUNOSE, Mihiro; BELL, Kathryn; ELLARD, Katie et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 14, pp 4613-4618, issn 0960-894X, 6 p.Article

Identification and hit-to-lead exploration of a novel series of histamine H4 receptor inverse agonistsCRAMP, Sue; DYKE, Hazel J; PORRES, Soraya et al.Bioorganic & medicinal chemistry letters (Print). 2010, Vol 20, Num 8, pp 2516-2519, issn 0960-894X, 4 p.Article

SAR studies around a series of triazolopyridines as potent and selective PI3Kγ inhibitorsBELL, Kathryn; SUNOSE, Mihiro; ELLARD, Kate et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 16, pp 5257-5263, issn 0960-894X, 7 p.Article

Discovery of novel PI3Kγ/δ inhibitors as potential agents for inflammationELLARD, Katie; SUNOSE, Mihiro; BELL, Kathryn et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 14, pp 4546-4549, issn 0960-894X, 4 p.Article

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsBANTSCHEFF, Marcus; EBERHARD, Dirk; READER, Valérie et al.Nature biotechnology (Print). 2007, Vol 25, Num 9, pp 1035-1044, issn 1087-0156, 10 p.Article

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexesBANTSCHEFF, Marcus; HOPF, Carsten; BOESCHE, Markus et al.Nature biotechnology (Print). 2011, Vol 29, Num 3, pp 255-265, issn 1087-0156, 11 p.Article